TRACON Pharmaceutical (TCON) Tops Q3 EPS by 40c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q3 EPS of $0.33, $0.40 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $493.26 million versus the consensus estimate of $3.55 million.

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• XP Inc. (XP) Tops Q2 EPS by 8c